You are here

Wegovy

Obesity Drug Market Set to Hit $100 Billion by 2035, BMO Says

Obesity Drug Market Set to Hit $100 Billion by 2035, BMO Says

Yahoo/Bloomberg

Flag link:

Novo Nordisk Dives After FDA Reportedly Finds 'Objectionable' Conditions At A Key Wegovy Plant

Novo Nordisk Dives After FDA Reportedly Finds 'Objectionable' Conditions At A Key Wegovy Plant

Investors Business Daily

drug manufacturing

Flag link:

Novo Nordisk hires private U.S. firm to handle some Wegovy pen assembly

Novo Nordisk hires private U.S. firm to handle some Wegovy pen assembly

Reuters

PCI Pharma Services

drug manufacturing

Flag link:

Novo Nordisk Is Already Working on Ozempic 2.0

Novo Nordisk Is Already Working on Ozempic 2.0

Motley Fool

Flag link:

Weight-loss drug maker Novo Nordisk becomes Europe’s most valuable company

Weight-loss drug maker Novo Nordisk becomes Europe’s most valuable company

FT.com

Flag link:

Novo Nordisk launches Wegovy for obese patients in UK

Novo Nordisk launches Wegovy for obese patients in UK

Pharmaceutical Business Review

Flag link:

Signal: Novo Nordisk market cap higher than Danish GDP due to obesity drugs

Signal: Novo Nordisk market cap higher than Danish GDP due to obesity drugs

Clinical Trials Arena

Flag link:

Wegovy costs $1.1m to prevent one heart attack, stroke, or cardiovascular death

Wegovy costs $1.1m to prevent one heart attack, stroke, or cardiovascular death

Airfinity

cardiovascular disease

Flag link:

Are weight loss drugs a win for the global economy?

Are weight loss drugs a win for the global economy?

Pharma Voice

Flag link:

Shares of Wegovy Partner Catalent Jump After Striking Deal With Activist Investor Elliott

Shares of Wegovy Partner Catalent Jump After Striking Deal With Activist Investor Elliott

Investopedia

Elliott Management

Flag link:

Why Wegovy's Sales Potential Could Be Massively Understated

Why Wegovy's Sales Potential Could Be Massively Understated

Motley Fool

Flag link:

Novo Nordisk set to launch weight loss drugs in more countries but in constrained fashion, CEO says

Novo Nordisk set to launch weight loss drugs in more countries but in constrained fashion, CEO says

Fierce Pharma

Flag link:

On a roll, Novo's star obesity drug Wegovy shows benefits in patients with heart failure

On a roll, Novo's star obesity drug Wegovy shows benefits in patients with heart failure

Fierce Pharma

clinical trials

Flag link:

Weight-Loss Drug Wegovy Will Launch In More Countries Despite Ongoing Struggles Over Stellar Demand, CEO Says

Weight-Loss Drug Wegovy Will Launch In More Countries Despite Ongoing Struggles Over Stellar Demand, CEO Says

Forbes

Lars Fruergaard Jorgensen

Flag link:

Novo Nordisk enlists Thermo Fisher as second Wegovy manufacturer: report

Novo Nordisk enlists Thermo Fisher as second Wegovy manufacturer: report

Medical Marketing and Media

drug manufacturing

Flag link:

Nearly Half Of Americans Polled Want Weight Loss Drugs But Many Lose Interest After Reading The Fine Print

Nearly Half Of Americans Polled Want Weight Loss Drugs But Many Lose Interest After Reading The Fine Print

Forbes

Flag link:

Novo Nordisk prolongs rationing Wegovy solutions

Novo Nordisk prolongs rationing Wegovy solutions

Beckers Hospital Review

Flag link:

In the era of blockbuster obesity drugs, a personalized approach could boost outcomes

In the era of blockbuster obesity drugs, a personalized approach could boost outcomes

Pharma Voice

Flag link:

Novo Nordisk posts 'best-case scenario' cardio outcomes data for star obesity drug Wegovy

Novo Nordisk posts 'best-case scenario' cardio outcomes data for star obesity drug Wegovy

Fierce Pharma

clinical trials

cardiovascular disease

Flag link:

New weight loss drugs carry high price tags and lots of questions for seniors

New weight loss drugs carry high price tags and lots of questions for seniors

Medical Marketing and Media

Flag link:

Pages